Is Botanix Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Botanix Pharmaceuticals Ltd (BOT.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Botanix Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Botanix Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Botanix Pharmaceuticals Ltd?

Muslim investors may consider investing in Botanix Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Botanix Pharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Botanix Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Botanix Pharmaceuticals Ltd updated?

The Shariah compliance status of Botanix Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Botanix Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Botanix Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Botanix Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BOT.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 20, 2025

Report Source: 2025 Annual Report

Botanix Pharmaceuticals Ltd. Stock Analysis BOT.AX

Australia Health Care Micro Cap Report: 2025 Annual

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

Key Statistics of Botanix Pharmaceuticals Ltd (BOT.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.03AUD0.03

Today's Open

AUD0.03

Volume

11.12M

P/E Ratio (TTM)

52 Week Range

AUD0.02AUD0.40

Market Cap

70.73M

Avg. Volume

4.02M

Dividend Yield

Financial Metrics & Statements of Botanix Pharmaceuticals Ltd (BOT.AX)

FAQ's for Botanix Pharmaceuticals Ltd (BOT.AX)

According to Musaffa’s Shariah screening methodology, Botanix Pharmaceuticals Ltd (BOT.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.